CVE-2024-26466: A DOM based cross-site scripting (XSS) vulnerability in the component /dom/ranges/Range-test-iframe.html of we
CVE-2024-26466 is a medium-severity flaw (CVSS 6.1) affecting web-platform-tests. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
A DOM based cross-site scripting (XSS) vulnerability in the component /dom/ranges/Range-test-iframe.html of web-platform-tests/wpt before commit 938e843 allows attackers to execute arbitrary Javascript via sending a crafted URL.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 6.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 0.4% (top 63%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2024-02-26 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2024-26466?
web-platform-tests: mitigate or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2024-26466 being exploited?
CVE-2024-26466 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2024-26466 affect?
CVE-2024-26466 affects web-platform-tests. Severity is medium (CVSS 6.1). A DOM based cross-site scripting (XSS) vulnerability in the component /dom/ranges/Range-test-iframe.html of web-platform-tests/wpt before commit 938e843 allows attackers to execute arbitrary Javascript via sending a crafted URL.
How urgent is CVE-2024-26466?
Priority 31/100. No elevated risk signals yet.